Filing Details

Accession Number:
0001720512-17-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-03 15:31:56
Reporting Period:
2017-10-26
Accepted Time:
2017-11-03 15:31:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
948320 Immudyne Inc. IMMD Medicinal Chemicals & Botanical Products (2833) 760238453
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1720512 Justin Schreiber 53 Calle Palmeras
Suite 802
San Juan PR 00901
President, Immudyne Pr Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Acquisiton 2017-10-26 2,700 $0.41 1,832,972 No 4 P Indirect JOJ Holdings, LLC
Common Stock, Par Value $0.01 Acquisiton 2017-11-03 135,721 $0.23 1,968,693 No 4 J Indirect JOJ Holdings, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect JOJ Holdings, LLC
No 4 J Indirect JOJ Holdings, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Warrant Acquisiton 2017-11-03 67,861 $0.40 67,861 $0.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
67,861 2017-11-03 2019-11-03 No 4 J Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.01 1,375,000 Indirect JLS Ventures, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, Par Value $0.01 Warrant $0.40 2017-01-01 2019-01-01 591,745 591,745 Indirect
Common Stock, Par Value $0.01 Warrant $0.40 2016-11-01 2018-11-01 217,391 217,391 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-01-01 591,745 591,745 Indirect
2018-11-01 217,391 217,391 Indirect
Footnotes
  1. Reporting person converted capital contributions to Immudyne PR, LLC pursuant to a subscription agreement. $31,215.94 was converted at $0.23 cents into 135,721 shares and 50% warrant coverage at $0.40.